XML 46 R25.htm IDEA: XBRL DOCUMENT v3.25.2
Stockholders' Equity
 12 Months Ended
Jun. 30, 2025
Equity [Abstract]  
Stockholders' Equity
13.
STOCKHOLDERS’ EQUITY

Preferred Stock

The Company is authorized to issue “blank check” preferred stock of up to 5,000 shares with such designations, rights and preferences as may be determined from time to time by the Board of Directors. Accordingly, the Board of Directors is empowered to issue, without stockholder approval, preferred stock with dividends, liquidation, conversion, voting or other rights which could decrease the amount of earnings and assets available for distribution to holders of the Company’s common stock. At June 30, 2025 and 2024, no preferred stock was issued or outstanding.

Accumulated Other Comprehensive Loss

The following table presents the changes in accumulated other comprehensive loss (“AOCL”):

 

 

Foreign
Currency
Translation
Adjustment,
Net

 

 

Deferred
Gains (Losses) on
Cash Flow
Hedging
Instruments,
Net

 

 

Deferred
(Losses) Gains on
Fair Value
Hedging
Instruments,
Net

 

 

Deferred
(Losses) Gains on
Net
Investment
Hedging
Instruments,
Net

 

 

Total

 

Balance at June 30, 2022

 

$

(168,225

)

 

$

519

 

 

$

500

 

 

$

2,724

 

 

$

(164,482

)

Other comprehensive income (loss) before reclassifications

 

 

30,197

 

 

 

15,390

 

 

 

(249

)

 

 

(1,022

)

 

 

44,316

 

Amounts reclassified into (income) loss

 

 

—

 

 

 

(5,011

)

 

 

434

 

 

 

(1,473

)

 

 

(6,050

)

Net change in accumulated other comprehensive income (loss) for the fiscal year ended June 30, 2023(1)

 

 

30,197

 

 

 

10,379

 

 

 

185

 

 

 

(2,495

)

 

 

38,266

 

Balance at June 30, 2023

 

 

(138,028

)

 

 

10,898

 

 

 

685

 

 

 

229

 

 

 

(126,216

)

Other comprehensive (loss) income before reclassifications

 

 

(9,045

)

 

 

5,545

 

 

 

342

 

 

 

1,390

 

 

 

(1,768

)

Amounts reclassified into income

 

 

—

 

 

 

(7,048

)

 

 

(730

)

 

 

(1,483

)

 

 

(9,261

)

Net change in accumulated other comprehensive loss for the fiscal year ended June 30, 2024(1)

 

 

(9,045

)

 

 

(1,503

)

 

 

(388

)

 

 

(93

)

 

 

(11,029

)

Balance at June 30, 2024

 

 

(147,073

)

 

 

9,395

 

 

 

297

 

 

 

136

 

 

 

(137,245

)

Other comprehensive income (loss) before reclassifications

 

 

71,324

 

 

 

(1,892

)

 

 

(1,670

)

 

 

(6,782

)

 

 

60,980

 

Amounts reclassified into (income) loss

 

 

—

 

 

 

(4,920

)

 

 

1,557

 

 

 

(1,425

)

 

 

(4,788

)

Net change in accumulated other comprehensive income (loss) for the fiscal year ended June 30, 2025(1)

 

 

71,324

 

 

 

(6,812

)

 

 

(113

)

 

 

(8,207

)

 

 

56,192

 

Balance at June 30, 2025

 

$

(75,749

)

 

$

2,583

 

 

$

184

 

 

$

(8,071

)

 

$

(81,053

)

 

(1)
See Note 17, Derivatives and Hedging Activities, for the amounts reclassified into income (expense) for deferred gains (losses) on hedging instruments recorded in the consolidated statements of operations during the fiscal years ended June 30, 2025, 2024, and 2023.

Share Repurchase Program

In January 2022, the Company’s Board of Directors authorized the repurchase of up to $200.0 million of the Company’s issued and outstanding common stock. Repurchases may be made from time to time in the open market, pursuant to pre-set trading plans, in private transactions or otherwise. The current 2022 authorization does not have a stated expiration date. The extent to which the Company repurchases its shares and the timing of such repurchases will depend upon market conditions and other corporate considerations. During the fiscal year ended June 30, 2025, the Company did not repurchase any shares under the repurchase program. As of June 30, 2025, the Company had $173.5 million of remaining authorization under the share repurchase program.